{"cluster": 36, "subcluster": 26, "abstract_summ": "Development of the novel therapeutic strategies targeting neutrophils may help reduce the overall disease fatality rate of COVID-19.COVID-2019 has progressed in around 10-15% of patients to an acute respiratory distress syndrome characterized by extensive pulmonary inflammation and elevated production of pro-inflammatory cytokines.The key role of oxidative stress in the pathogenesis of severe COVID-19 implies that therapeutic counterbalancing of ROS by antioxidants such as vitamin C or NAC and/or by antagonizing ROS production by cells of the MPS and neutrophil granulocytes and/or by blocking of TNF-\u03b1 can prevent COVID-19 from becoming severe.SARS-CoV2 infection can lead to alterations of redox balance in infected cells through modulation of NAD + biosynthesis, PARP function along with altering proteasome and mitochondrial function in the cell thereby leading to enhanced cell stress responses which further exacerbate inflammation.It increases the formation of neutrophil extracellular traps (NETs) and suppresses the adaptive arm of the immune system, i.e. T cells that are necessary to kill virus-infected cells.In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils\u2014the ability to form neutrophil extracellular traps (NETs)\u2014may contribute to organ damage and mortality in COVID-19.", "title_summ": "Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular trapsDevilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppressionTargeting potential drivers of COVID-19: Neutrophil extracellular trapsReactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention", "title_abstract_phrases": "Development of the novel therapeutic strategies targeting neutrophils may help reduce the overall disease fatality rate of COVID-19.Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular trapsCOVID-2019 has progressed in around 10-15% of patients to an acute respiratory distress syndrome characterized by extensive pulmonary inflammation and elevated production of pro-inflammatory cytokines.Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.The COVID-19 pandemic is progressing worldwide with an alarming death toll.The key role of oxidative stress in the pathogenesis of severe COVID-19 implies that therapeutic counterbalancing of ROS by antioxidants such as vitamin C or NAC and/or by antagonizing ROS production by cells of the MPS and neutrophil granulocytes and/or by blocking of TNF-\u03b1 can prevent COVID-19 from becoming severe.Graphical abstractDevilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppressionPandemic coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and poses an unprecedented challenge to healthcare systems due to the lack of a vaccine and specific treatment options.SARS-CoV2 infection can lead to alterations of redox balance in infected cells through modulation of NAD + biosynthesis, PARP function along with altering proteasome and mitochondrial function in the cell thereby leading to enhanced cell stress responses which further exacerbate inflammation."}